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Computational fluid dynamics (CFD) can be used to analyze blood flow and to predict 
hemodynamic outcomes after interventions for coarctation of the aorta and other cardiovascular 
diseases. We report the first use of cardiac 3-dimensional rotational angiography for CFD and 
show not only feasibility but also validation of its hemodynamic computations with catheter-






















Aortic coarctation occurs in 5–8% of patients with congenital heart disease and causes upper-
body hypertension and long-term sequelae, including persistent hypertension, stroke, coronary 
artery disease, aneurysm formation, and decreased life expectancy (1, 2). Treatment is 
recommended for a peak systolic gradient (PSG) of 20 mmHg and is reasonable for less than 20 
mmHg, if there is systemic hypertension (3). In older children through adults, stent therapy is 
becoming standard of care (4). 
 
The morphology of coarctation ranges from a discrete lesion, commonly at the aortic isthmus, to 
diffuse arch hypoplasia. This diversity results in a patient-specific anatomical and hemodynamic 
environment. The presence of any degree of transverse arch hypoplasia complicates the decision 
making process for treatment, such that it is unclear if stenting the isthmus lesion will achieve 
adequate gradient reduction. Even mild residual hypoplasia can cause long-term sequelae and 
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increase the risk of chronic hypertension (5). As such, management requires an individualized 
treatment plan to obtain the best physiologic result. At present, however, standard imaging 
techniques and hemodynamic assessment at catheterization cannot predict the post-stent 
hemodynamic outcome. In this regard, computational fluid dynamics (CFD) techniques, in 
combination with virtual stenting, may enable treatment to be individualized and the 
physiological results to be anticipated before actually performing the intervention.  
 
CFD uses computer-based simulation to analyze fluid flow and has been used for decades to 
analyze blood flow in the cardiovascular system, particularly in the coronary arteries, the aorta, 
and single ventricle heart disease (6, 7, 8). While CFD is approved for clinical use in coronary 
artery disease, it is not routinely used in congenital heart disease for diagnosis or clinical 
decision making (9). Clinical data supporting accuracy of CFD in congenital heart disease are 
emerging. Early work using magnetic resonance imaging (MRI) and computed tomography 
angiography (CTA)-based CFD to predict invasively obtained gradients non-invasively in 
coarctation patients has been described (10,11). While CFD will likely find clinical applicability 
in avoiding invasive catheterization for pressure gradient measurements in the future, CFD could 
also be used in the cardiac catheterization laboratory (CCL) for virtual interventions and 
predictive modeling to individualize interventions during the catheterization procedure, without a 
preceding MRI or CTA. 
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In this case series, we utilize a new technology to allow CFD to be performed using data 
obtained solely in the CCL, without the need for MRI, CTA, or other pre-operative imaging. This 
technology uses an angiographic CT or CT-like image obtained from 3-dimensional rotational 
angiography (3DRA), specifically a DynaCT acquisition system (Siemens Healthcare GmbH, 
Erlangen, Germany). Due to the computational speed of this unique CFD model, use of 3DRA 
for CFD could allow for complete hemodynamic assessment, virtual interventions and predictive 
modeling, all while the patient is in the CCL, prior to performing the clinical intervention. In the 
future, this would allow for treatment planning to be personalized for each patient, including 
stent length, diameter, and location.  
 
We sought to test the feasibility of using data obtained solely in the CCL for CFD in 3 patients 
undergoing coarctation stenting and compared the PSG computed by CFD before and after 
virtual stenting with that obtained directly by catheter before and after actual stent implantation. 
As this was performed to test feasibility, the CFD was run after the procedure, and clinical 
decisions were not based on the results. We hypothesized that the new CFD model would 
calculate PSGs that would correlate with those obtained by direct catheter measurement with an 
absolute error of <5 mmHg, which has been shown when comparing catheter-derived gradients 
to MRI-based CFD-derived gradients (10,11). We are the first to report cardiac CFD being 
performed from 3DRA and catheterization hemodynamic data alone. 
 





Written informed consent was obtained from the patients’ guardians. The study was approved by 
the Institutional Review Board of the two participating centers. Cardiac catheterization was 
performed using a biplane Siemens Artis Zee angiographic system (Siemens Healthcare GmbH, 
Erlangen, Germany). General anesthesia was used for all patients. Prior to stenting, a complete 
hemodynamic catheterization was performed, including thermodilution cardiac output (TDCO) 
measurements. Using a 3.5F Millar Mikro-Cath™ Diagnostic Pressure Catheter (Millar Inc., 
Houston, TX) through a guide catheter, pressures were obtained in the left ventricle, ascending 
aorta just above the aortic valve, innominate artery, left carotid artery, left subclavian artery, and 
descending aorta at the level of the diaphragm.  
 
A pre-stent 3DRA was performed with a 6F pigtail catheter in the left ventricle. A contrast 
mixture of 50% contrast (contrast type and dose were institutional standard for 3D) and 50% 
saline was injected over 7 seconds with a 2 second x-ray delay and a 5-second spin. During 
injection, rapid right ventricular pacing at 180-240 paces per minute was performed to decrease 
the systolic blood pressure by 50%, and a breath hold was performed to minimize motion 
artifact. A low dose spin protocol was used (12 mGy/frame, 1.5 degrees per frame, 30 frames per 
second). The 2D biplane aortic angiogram was used, when available, to determine pulsatility of 
the aorta for elasticity assessment. Aortic coarctation stenting was performed at the operators’ 
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discretion. A post-stent 3DRA was performed, using the same protocol as for the pre-stent 
3DRA, and a hemodynamic catheterization was repeated. 
 
CFD Technical Protocol 
The CFD model uses a reduced order formulation of the equations of fluid flow that is designed 
to provide accurate representation of cross-section averaged quantities, such as pressure loss and 
flow in each branch, while sacrificing the ability to capture local flow variations. The model has 
the advantage of being rapid enough to be valuable as a clinical application, taking an average of 
3 minutes of computation time per patient, compared to several hours for typical CFD 
simulators. The model is described in more detail in previous publications (10), where it is 
shown to provide good predictions of catheter-measured PSG based on MR and phase-contrast 
imaging derived flow rates. Specifically, the reduced-order multiscale fluid-structure interaction 
blood flow model is employed to compute pre- and post-stenting hemodynamics. It is based on a 
quasi one-dimensional model for the large arteries and a lumped parameter model (three-element 
Windkessel model), which accounts for the effect of the distal vasculature. To enable accurate 
pressure computation in the coarctation region, a locally defined pressure-drop model is 
embedded into the reduced-order blood flow model (12). Time-varying flow rate profiles are 
used as the inlet boundary condition. A parameter estimation framework is employed for 
personalizing the hemodynamic computations, comprising two calibration procedures, focusing 
on the cycle-averaged and time-dependent quantities. 




In the current work, we extended this model to 3DRA for the anatomic assessment, using 
thermodilution cardiac output to set the inlet boundary condition. Invasively measured pressures 
in the ascending aorta, along with angiographically measured aortic diameters, were used to 
personalize the model parameters, and the PSG across the coarctation was then computed. The 
coarctation geometry was modified to simulate the effect of stenting. The virtual stent location 
was chosen independently from the actual stenting procedure. The stent length and diameter 
were chosen to relieve all stenosis in the descending thoracic aorta, matching the diameter of the 
stent to the aortic diameter on either end of the virtual stent. There were no significant 
differences in the post-stenting actual and predicted anatomical configurations. A post-stent PSG 
was computed, using the same flowrate and personalized model properties as the pre-stent 
computations, in order to simulate real-time work in the CCL (Figure 1). The computational run 
times for the three cases were 147, 190, and 176 seconds (mean time 171 ± 22 seconds). 
 
Case 1 
A 13-year-old 55.5 kg female was referred to the CCL for a severe native coarctation of the aorta 
with an arm-leg cuff PSG of 56 mmHg with upper extremity hypertension (146/52 mmHg). 
Catheterization revealed a discrete, severe coarctation distal to the left subclavian artery. PSG 
was 41 mmHg with a TDCO of 4.7 L/min (Table I), and the CFD processor predicted a PSG of 
40 mmHg. The coarctation was treated with a 36 mm long Cheatham Platinum (CP) stent 
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(NuMED, Hopkinton, NY) mounted on a 12 mm Z-Med II-X balloon catheter (NuMED, 
Hopkinton, NY). The residual PSG across the arch was 14 mmHg, and virtual stenting predicted 
a residual PSG of 10 mmHg (Figure 2 and Table II). 
 
Case 2  
A 16-year-old 69.6 kg male came to the CCL for treatment of a native coarctation of the aorta, 
due to an arm-leg cuff PSG of 50 mmHg with upper extremity hypertension (150/82 mmHg). He 
also had a bicuspid aortic valve, mild aortic regurgitation, and a dilated aortic root. 
Catheterization showed a moderate, discrete coarctation distal to the left subclavian artery with a 
PSG of 29 mmHg and TDCO of 5.7 L/min. CFD predicted a PSG of 29 mmHg. The coarctation 
was treated with a 45 mm long CP stent mounted on a 15 mm Z-Med II-X balloon catheter. The 
residual PSG was 3 mmHg, and, after virtual stenting, the PSG was computed as 2 mmHg 
(Figure 3 and Table II). 
 
Case 3  
A 10-year-old 34.8 kg female underwent catheterization for a native coarctation of the aorta, due 
to an arm-leg cuff PSG of 32 mmHg without upper extremity hypertension. A mild, discrete 
coarctation in the mid-thoracic descending aorta resulted in a PSG of 19 mmHg with a TDCO of 
3.9 L/min. CFD computed a PSG of 18 mmHg. The coarctation was treated with a 39 mm long 
covered CP stent mounted on a 16 mm Balloon in Balloon catheter (NuMED, Hopkinton, NY). 
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There was no residual gradient from ascending aorta to descending aorta at catheterization and or 
in the model with virtual stenting (Figure 4 and Table II). 
 
Discussion 
Since the 1990s, MRI-based CFD advanced from a preclinical modality to clinical application by 
evaluating pathophysiology, surgical and catheter-based treatment planning, and outcome 
prediction. However, clinical data to prove the accuracy of the data obtained from CFD in 
congenital heart disease are still limited. Aside from case reports, two studies have compared 
catheter-based and CFD-based gradients before and after aortic stenting and virtual stenting, 
respectively. First, Goubergrits et al evaluated 13 patients who underwent catheterization and 
preceding MRI, 1 day to 4 weeks apart, for coarctation of the aorta (11). MRI included 3D 
whole-heart and flow-sensitive 4D velocity-encoded sequences (Gyrotools, Zurich, Switzerland). 
CFD assessments were performed using Fluent® 6.3.26 (Ansys, Canonsburg, PA), and the post-
treatment aortic geometry was virtually reconstructed from x-ray images. Pre-stent PSGs 
measured by catheter- and MRI-based CFD correlated significantly with a correlation coefficient 
of 0.97 and an absolute error of -0.5±0.33 mmHg. Post-stent PSGs also correlated significantly 
with a correlation coefficient of 0.87 and absolute error of 3.0±2.91 mmHg (11). 
 
Second, Ralovich et al investigated data sets from 6 coarctation patients who had undergone pre- 
and post-intervention MRI and catheterizations (10). Using MRI-based CFD and virtual stenting, 
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there was good agreement between CFD computed PSGs and catheter PSGs with an average 
absolute error of 2.38±0.82 mmHg (pre-stenting), 1.10±0.63 mmHg (post-stenting), and 
4.99±3.00 mmHg (virtual stenting).  
 
To date, 3DRA-based CFD has been used clinically to understand the hemodynamics of brain 
aneurysms and to aid in treatment planning but has not been used in cardiac disease. Because of 
its high spatial resolution, low sensitivity to patient motion, and low visibility of bone, 3DRA has 
been used as the imaging gold standard when comparing CFD using MRI and CTA (13). Our 
first use of this imaging modality to perform cardiac CFD not only shows feasibility but also 
begins to validate its hemodynamic computations with catheter-based measurements, as all the 
gradients were within 5 mmHg of absolute error. 
 
While CFD predicted the gradients with minimal absolute error, the post-stenting absolute 
pressures were not predicted accurately in all cases. The personalization for both the pre- and 
virtual post-stenting CFD based computations was performed using solely pre-stenting 
hemodynamic measurements, in order to mimic predictive modeling used real-time in the 
catheterization laboratory, during which only pre-stent hemodynamics would be available. For 
example, in Case #1, the patient’s hemodynamics changed quite significantly between the pre- 
and post-stent settings (Table I) with the ascending aortic pressure and TDCO decreasing after 
stent placement. Despite using the pre-stent hemodynamics in the model, a prediction error of 4 
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mmHg indicated that the PSG prediction was quite robust and that its accuracy was only 
marginally affected by the change in post-stent hemodynamics. 
 
3DRA-based cardiac CFD is the first step to perform virtual interventions real-time in the CCL 
and to allow CFD to guide management decisions during cardiac catheterization. Previous 
cardiac predictive modeling has used pre-procedural MRI or CTA (14,15). Our novel workflow 
could allow for CFD-guided personalized management decisions even when pre-procedural 
advanced imaging is not performed (14,15). 
 
Limitations 
The small prediction error (<5 mmHg) is one limitation of CFD, and a detailed uncertainty 
quantification analysis is planned for future studies. Error can come from modeling assumptions, 
anatomical reconstruction errors, inaccurate elastic wall modeling, and inaccuracies in the 
physiological measurements, such as thermodilution cardiac output. The reduced-order 
multiscale model is also limited by its inability to produce 3D streamlines, vortices, and wall 
shear stress. It was chosen for performing the blood flow computations, mainly due to the 
significantly reduced computation time, with an aim of running the calculations real-time, while 
the patient is on the catheterization table.  
 
Conclusion 
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The ability to have patient-specific predictive modeling with hemodynamic assessment in the 
CCL will allow clinical decisions regarding stent therapy to be based on robust data, as opposed 
to guessing and assumptions, as it is done now. This may revolutionize the way we make clinical 
decisions and significantly improve care, if this can be done real-time during the catheterization. 
Widespread use of this technology will require large-scale studies to assure reliability and 
validity and to move CFD assessment into the CCL. 
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Figure 1: 3D Rotational Angiography Computational Fluid Dynamics Workflow: (a) 3D 
rotational angiogram (arrow showing discrete coarctation), (b) segmentation, (c) final 3D 
segmented model, (d) boundary conditions added, (e) gradient prediction, (f) virtual stent 
implantation with boundary conditions, and (g) post-stent gradient prediction  
Asc, Ascending; Desc, Descending 
 
Figure 2: Case 1 (a) Dyna CT reconstruction and (b) pressure predictions pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
 
Figure 3: Case 2 (a) Dyna CT reconstruction and (b) pressure predictions pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
 
Figure 4: Case 3 (a) Dyna CT reconstruction and pressure predictions (b) pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
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Table I. (A) Pre-stent and (B) post-stent physiologic and anatomical parameters measured at 
catheterization  
A. Pre-stent 














1 104/62 63/53 4.7 101 4.4 16 
2 92/51 63/51 5.7 64 6.8 40 











1 85/52 71/48 3.7 
2 100/54 97/61 6.4 
3 109/71 110/74 5.7 
AAo, Ascending aorta 
DAo, Descending aorta 
BP, Blood pressure 
TDCO, thermodilution cardiac output 
*Pre-stent TDCO was used for post-stent CFD in order to simulate real-time workflow in the 
cardiac catheterization laboratory 
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Table II. Pre-stent and post-stent peak systolic gradients (mmHg) measured by direct 
catheterization pullback (ascending aortic systolic pressure – descending aortic systolic pressure) 
and by Computational Fluid Dynamics  
 Pre-Stent Post-Stent 
Measured CFD* Measured CFD* 
Case 1 41 40 14 10 
Case 2 29 29 3 2 
Case 3 19 18 0 0 
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Computational fluid dynamics (CFD) can be used to analyze blood flow and to predict 
hemodynamic outcomes after interventions for coarctation of the aorta and other cardiovascular 
diseases. We report the first use of cardiac 3-dimensional rotational angiography for CFD and 
show not only feasibility but also validation of its hemodynamic computations with catheter-






















Aortic coarctation occurs in 5–8% of patients with congenital heart disease and causes upper-
body hypertension and long-term sequelae, including persistent hypertension, stroke, coronary 
artery disease, aneurysm formation, and decreased life expectancy (1, 2). Treatment is 
recommended for a peak systolic gradient (PSG) of 20 mmHg and is reasonable for less than 20 
mmHg, if there is systemic hypertension (3). In older children through adults, stent therapy is 
becoming standard of care (4). 
 
The morphology of coarctation ranges from a discrete lesion, commonly at the aortic isthmus, to 
diffuse arch hypoplasia. This diversity results in a patient-specific anatomical and hemodynamic 
environment. The presence of any degree of transverse arch hypoplasia complicates the decision 
making process for treatment, such that it is unclear if stenting the isthmus lesion will achieve 
adequate gradient reduction. Even mild residual hypoplasia can cause long-term sequelae and 
increase the risk of chronic hypertension (5). As such, management requires an individualized 
treatment plan to obtain the best physiologic result. At present, however, standard imaging 
techniques and hemodynamic assessment at catheterization cannot predict the post-stent 
hemodynamic outcome. In this regard, computational fluid dynamics (CFD) techniques, in 
combination with virtual stenting, may enable treatment to be individualized and the 
physiological results to be anticipated before actually performing the intervention.  
 
CFD uses computer-based simulation to analyze fluid flow and has been used for decades to 
analyze blood flow in the cardiovascular system, particularly in the coronary arteries, the aorta, 
and single ventricle heart disease (6, 7, 8). While CFD is approved for clinical use in coronary 
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artery disease, it is not routinely used in congenital heart disease for diagnosis or clinical 
decision making (9). Clinical data supporting accuracy of CFD in congenital heart disease are 
emerging. Early work using magnetic resonance imaging (MRI) and computed tomography 
angiography (CTA)-based CFD to predict invasively obtained gradients non-invasively in 
coarctation patients has been described (10,11). While CFD will likely find clinical applicability 
in avoiding invasive catheterization for pressure gradient measurements in the future, CFD could 
also be used in the cardiac catheterization laboratory (CCL) for virtual interventions and 
predictive modeling to individualize interventions during the catheterization procedure, without a 
preceding MRI or CTA. 
 
In this case series, we utilize a new technology to allow CFD to be performed using data 
obtained solely in the CCL, without the need for MRI, CTA, or other pre-operative imaging. This 
technology uses an angiographic CT or CT-like image obtained from 3-dimensional rotational 
angiography (3DRA), specifically a DynaCT acquisition system (Siemens Healthcare GmbH, 
Erlangen, Germany). Due to the computational speed of this unique CFD model, use of 3DRA 
for CFD could allow for complete hemodynamic assessment, virtual interventions and predictive 
modeling, all while the patient is in the CCL, prior to performing the clinical intervention. In the 
future, this would allow for treatment planning to be personalized for each patient, including 
stent length, diameter, and location.  
 
We sought to test the feasibility of using data obtained solely in the CCL for CFD in 3 patients 
undergoing coarctation stenting and compared the PSG computed by CFD before and after 
virtual stenting with that obtained directly by catheter before and after actual stent implantation. 
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As this was performed to test feasibility, the CFD was run after the procedure, and clinical 
decisions were not based on the results. We hypothesized that the new CFD model would 
calculate PSGs that would correlate with those obtained by direct catheter measurement with an 
absolute error of <5 mmHg, which has been shown when comparing catheter-derived gradients 
to MRI-based CFD-derived gradients (10,11). We are the first to report cardiac CFD being 




Written informed consent was obtained from the patients’ guardians. The study was approved by 
the Institutional Review Board of the two participating centers. Cardiac catheterization was 
performed using a biplane Siemens Artis Zee angiographic system (Siemens Healthcare GmbH, 
Erlangen, Germany). General anesthesia was used for all patients. Prior to stenting, a complete 
hemodynamic catheterization was performed, including thermodilution cardiac output (TDCO) 
measurements. Using a 3.5F Millar Mikro-Cath™ Diagnostic Pressure Catheter (Millar Inc., 
Houston, TX) through a guide catheter, pressures were obtained in the left ventricle, ascending 
aorta just above the aortic valve, innominate artery, left carotid artery, left subclavian artery, and 
descending aorta at the level of the diaphragm.  
 
A pre-stent 3DRA was performed with a 6F pigtail catheter in the left ventricle. A contrast 
mixture of 50% contrast (contrast type and dose were institutional standard for 3D) and 50% 
saline was injected over 7 seconds with a 2 second x-ray delay and a 5-second spin. During 
injection, rapid right ventricular pacing at 180-240 paces per minute was performed to decrease 
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the systolic blood pressure by 50%, and a breath hold was performed to minimize motion 
artifact. A low dose spin protocol was used (12 mGy/frame, 1.5 degrees per frame, 30 frames per 
second). The 2D biplane aortic angiogram was used, when available, to determine pulsatility of 
the aorta for elasticity assessment. Aortic coarctation stenting was performed at the operators’ 
discretion. A post-stent 3DRA was performed, using the same protocol as for the pre-stent 
3DRA, and a hemodynamic catheterization was repeated. 
 
CFD Technical Protocol 
The CFD model uses a reduced order formulation of the equations of fluid flow that is designed 
to provide accurate representation of cross-section averaged quantities, such as pressure loss and 
flow in each branch, while sacrificing the ability to capture local flow variations. The model has 
the advantage of being rapid enough to be valuable as a clinical application, taking an average of 
3 minutes of computation time per patient, compared to several hours for typical CFD 
simulators. The model is described in more detail in previous publications (10), where it is 
shown to provide good predictions of catheter-measured PSG based on MR and phase-contrast 
imaging derived flow rates. Specifically, the reduced-order multiscale fluid-structure interaction 
blood flow model is employed to compute pre- and post-stenting hemodynamics. It is based on a 
quasi one-dimensional model for the large arteries and a lumped parameter model (three-element 
Windkessel model), which accounts for the effect of the distal vasculature. To enable accurate 
pressure computation in the coarctation region, a locally defined pressure-drop model is 
embedded into the reduced-order blood flow model (12). Time-varying flow rate profiles are 
used as the inlet boundary condition. A parameter estimation framework is employed for 
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personalizing the hemodynamic computations, comprising two calibration procedures, focusing 
on the cycle-averaged and time-dependent quantities. 
 
In the current work, we extended this model to 3DRA for the anatomic assessment, using 
thermodilution cardiac output to set the inlet boundary condition. Invasively measured pressures 
in the ascending aorta, along with angiographically measured aortic diameters, were used to 
personalize the model parameters, and the PSG across the coarctation was then computed. The 
coarctation geometry was modified to simulate the effect of stenting. The virtual stent location 
was chosen independently from the actual stenting procedure. The stent length and diameter 
were chosen to relieve all stenosis in the descending thoracic aorta, matching the diameter of the 
stent to the aortic diameter on either end of the virtual stent. There were no significant 
differences in the post-stenting actual and predicted anatomical configurations. A post-stent PSG 
was computed, using the same flowrate and personalized model properties as the pre-stent 
computations, in order to simulate real-time work in the CCL (Figure 1). The computational run 
times for the three cases were 147, 190, and 176 seconds (mean time 171 ± 22 seconds). 
 
Case 1 
A 13-year-old 55.5 kg female was referred to the CCL for a severe native coarctation of the aorta 
with an arm-leg cuff PSG of 56 mmHg with upper extremity hypertension (146/52 mmHg). 
Catheterization revealed a discrete, severe coarctation distal to the left subclavian artery. PSG 
was 41 mmHg with a TDCO of 4.7 L/min (Table I), and the CFD processor predicted a PSG of 
40 mmHg. The coarctation was treated with a 36 mm long Cheatham Platinum (CP) stent 
(NuMED, Hopkinton, NY) mounted on a 12 mm Z-Med II-X balloon catheter (NuMED, 
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Hopkinton, NY). The residual PSG across the arch was 14 mmHg, and virtual stenting predicted 
a residual PSG of 10 mmHg (Figure 2 and Table II). 
 
Case 2  
A 16-year-old 69.6 kg male came to the CCL for treatment of a native coarctation of the aorta, 
due to an arm-leg cuff PSG of 50 mmHg with upper extremity hypertension (150/82 mmHg). He 
also had a bicuspid aortic valve, mild aortic regurgitation, and a dilated aortic root. 
Catheterization showed a moderate, discrete coarctation distal to the left subclavian artery with a 
PSG of 29 mmHg and TDCO of 5.7 L/min. CFD predicted a PSG of 29 mmHg. The coarctation 
was treated with a 45 mm long CP stent mounted on a 15 mm Z-Med II-X balloon catheter. The 
residual PSG was 3 mmHg, and, after virtual stenting, the PSG was computed as 2 mmHg 
(Figure 3 and Table II). 
 
Case 3  
A 10-year-old 34.8 kg female underwent catheterization for a native coarctation of the aorta, due 
to an arm-leg cuff PSG of 32 mmHg without upper extremity hypertension. A mild, discrete 
coarctation in the mid-thoracic descending aorta resulted in a PSG of 19 mmHg with a TDCO of 
3.9 L/min. CFD computed a PSG of 18 mmHg. The coarctation was treated with a 39 mm long 
covered CP stent mounted on a 16 mm Balloon in Balloon catheter (NuMED, Hopkinton, NY). 
There was no residual gradient from ascending aorta to descending aorta at catheterization and or 
in the model with virtual stenting (Figure 4 and Table II). 
 
Discussion 
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Since the 1990s, MRI-based CFD advanced from a preclinical modality to clinical application by 
evaluating pathophysiology, surgical and catheter-based treatment planning, and outcome 
prediction. However, clinical data to prove the accuracy of the data obtained from CFD in 
congenital heart disease are still limited. Aside from case reports, two studies have compared 
catheter-based and CFD-based gradients before and after aortic stenting and virtual stenting, 
respectively. First, Goubergrits et al evaluated 13 patients who underwent catheterization and 
preceding MRI, 1 day to 4 weeks apart, for coarctation of the aorta (11). MRI included 3D 
whole-heart and flow-sensitive 4D velocity-encoded sequences (Gyrotools, Zurich, Switzerland). 
CFD assessments were performed using Fluent® 6.3.26 (Ansys, Canonsburg, PA), and the post-
treatment aortic geometry was virtually reconstructed from x-ray images. Pre-stent PSGs 
measured by catheter- and MRI-based CFD correlated significantly with a correlation coefficient 
of 0.97 and an absolute error of -0.5±0.33 mmHg. Post-stent PSGs also correlated significantly 
with a correlation coefficient of 0.87 and absolute error of 3.0±2.91 mmHg (11). 
 
Second, Ralovich et al investigated data sets from 6 coarctation patients who had undergone pre- 
and post-intervention MRI and catheterizations (10). Using MRI-based CFD and virtual stenting, 
there was good agreement between CFD computed PSGs and catheter PSGs with an average 
absolute error of 2.38±0.82 mmHg (pre-stenting), 1.10±0.63 mmHg (post-stenting), and 
4.99±3.00 mmHg (virtual stenting).  
 
To date, 3DRA-based CFD has been used clinically to understand the hemodynamics of brain 
aneurysms and to aid in treatment planning but has not been used in cardiac disease. Because of 
its high spatial resolution, low sensitivity to patient motion, and low visibility of bone, 3DRA has 
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been used as the imaging gold standard when comparing CFD using MRI and CTA (13). Our 
first use of this imaging modality to perform cardiac CFD not only shows feasibility but also 
begins to validate its hemodynamic computations with catheter-based measurements, as all the 
gradients were within 5 mmHg of absolute error. 
 
While CFD predicted the gradients with minimal absolute error, the post-stenting absolute 
pressures were not predicted accurately in all cases. The personalization for both the pre- and 
virtual post-stenting CFD based computations was performed using solely pre-stenting 
hemodynamic measurements, in order to mimic predictive modeling used real-time in the 
catheterization laboratory, during which only pre-stent hemodynamics would be available. For 
example, in Case #1, the patient’s hemodynamics changed quite significantly between the pre- 
and post-stent settings (Table I) with the ascending aortic pressure and TDCO decreasing after 
stent placement. Despite using the pre-stent hemodynamics in the model, a prediction error of 4 
mmHg indicated that the PSG prediction was quite robust and that its accuracy was only 
marginally affected by the change in post-stent hemodynamics. 
 
3DRA-based cardiac CFD is the first step to perform virtual interventions real-time in the CCL 
and to allow CFD to guide management decisions during cardiac catheterization. Previous 
cardiac predictive modeling has used pre-procedural MRI or CTA (14,15). Our novel workflow 
could allow for CFD-guided personalized management decisions even when pre-procedural 
advanced imaging is not performed (14,15). 
 
Limitations 
This article is protected by copyright. All rights reserved.
11 
 
The small prediction error (<5 mmHg) is one limitation of CFD, and a detailed uncertainty 
quantification analysis is planned for future studies. Error can come from modeling assumptions, 
anatomical reconstruction errors, inaccurate elastic wall modeling, and inaccuracies in the 
physiological measurements, such as thermodilution cardiac output. The reduced-order 
multiscale model is also limited by its inability to produce 3D streamlines, vortices, and wall 
shear stress. It was chosen for performing the blood flow computations, mainly due to the 
significantly reduced computation time, with an aim of running the calculations real-time, while 
the patient is on the catheterization table.  
 
Conclusion 
The ability to have patient-specific predictive modeling with hemodynamic assessment in the 
CCL will allow clinical decisions regarding stent therapy to be based on robust data, as opposed 
to guessing and assumptions, as it is done now. This may revolutionize the way we make clinical 
decisions and significantly improve care, if this can be done real-time during the catheterization. 
Widespread use of this technology will require large-scale studies to assure reliability and 
validity and to move CFD assessment into the CCL. 
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Figure 1: 3D Rotational Angiography Computational Fluid Dynamics Workflow: (a) 3D 
rotational angiogram (arrow showing discrete coarctation), (b) segmentation, (c) final 3D 
segmented model, (d) boundary conditions added, (e) gradient prediction, (f) virtual stent 
implantation with boundary conditions, and (g) post-stent gradient prediction  
Asc, Ascending; Desc, Descending 
 
Figure 2: Case 1 (a) Dyna CT reconstruction and (b) pressure predictions pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
 
Figure 3: Case 2 (a) Dyna CT reconstruction and (b) pressure predictions pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
 
Figure 4: Case 3 (a) Dyna CT reconstruction and pressure predictions (b) pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
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Computational fluid dynamics (CFD) can be used to analyze blood flow and to predict 
hemodynamic outcomes after interventions for coarctation of the aorta and other cardiovascular 
diseases. We report the first use of cardiac 3-dimensional rotational angiography for CFD and 
show not only feasibility but also validation of its hemodynamic computations with catheter-






















Aortic coarctation occurs in 5–8% of patients with congenital heart disease and causes upper-
body hypertension and long-term sequelae, including persistent hypertension, stroke, coronary 
artery disease, aneurysm formation, and decreased life expectancy (1, 2). Treatment is 
recommended for a peak systolic gradient (PSG) of 20 mmHg and is reasonable for less than 20 
mmHg, if there is systemic hypertension (3). In older children through adults, stent therapy is 
becoming standard of care (4). 
 
The morphology of coarctation ranges from a discrete lesion, commonly at the aortic isthmus, to 
diffuse arch hypoplasia. This diversity results in a patient-specific anatomical and hemodynamic 
environment. The presence of any degree of transverse arch hypoplasia complicates the decision 
making process for treatment, such that it is unclear if stenting the isthmus lesion will achieve 
adequate gradient reduction. Even mild residual hypoplasia can cause long-term sequelae and 
increase the risk of chronic hypertension (5). As such, management requires an individualized 
treatment plan to obtain the best physiologic result. At present, however, standard imaging 
techniques and hemodynamic assessment at catheterization cannot predict the post-stent 
hemodynamic outcome. In this regard, computational fluid dynamics (CFD) techniques, in 
combination with virtual stenting, may enable treatment to be individualized and the 
physiological results to be anticipated before actually performing the intervention.  
 
CFD uses computer-based simulation to analyze fluid flow and has been used for decades to 
analyze blood flow in the cardiovascular system, particularly in the coronary arteries, the aorta, 
and single ventricle heart disease (6, 7, 8). While CFD is approved for clinical use in coronary 
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artery disease, it is not routinely used in congenital heart disease for diagnosis or clinical 
decision making (9). Clinical data supporting accuracy of CFD in congenital heart disease are 
emerging. Early work using magnetic resonance imaging (MRI) and computed tomography 
angiography (CTA)-based CFD to predict invasively obtained gradients non-invasively in 
coarctation patients has been described (10,11). While CFD will likely find clinical applicability 
in avoiding invasive catheterization for pressure gradient measurements in the future, CFD could 
also be used in the cardiac catheterization laboratory (CCL) for virtual interventions and 
predictive modeling to individualize interventions during the catheterization procedure, without a 
preceding MRI or CTA. 
 
In this case series, we utilize a new technology to allow CFD to be performed using data 
obtained solely in the CCL, without the need for MRI, CTA, or other pre-operative imaging. This 
technology uses an angiographic CT or CT-like image obtained from 3-dimensional rotational 
angiography (3DRA), specifically a DynaCT acquisition system (Siemens Healthcare GmbH, 
Erlangen, Germany). Due to the computational speed of this unique CFD model, use of 3DRA 
for CFD could allow for complete hemodynamic assessment, virtual interventions and predictive 
modeling, all while the patient is in the CCL, prior to performing the clinical intervention. In the 
future, this would allow for treatment planning to be personalized for each patient, including 
stent length, diameter, and location.  
 
We sought to test the feasibility of using data obtained solely in the CCL for CFD in 3 patients 
undergoing coarctation stenting and compared the PSG computed by CFD before and after 
virtual stenting with that obtained directly by catheter before and after actual stent implantation. 
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As this was performed to test feasibility, the CFD was run after the procedure, and clinical 
decisions were not based on the results. We hypothesized that the new CFD model would 
calculate PSGs that would correlate with those obtained by direct catheter measurement with an 
absolute error of <5 mmHg, which has been shown when comparing catheter-derived gradients 
to MRI-based CFD-derived gradients (10,11). We are the first to report cardiac CFD being 




Written informed consent was obtained from the patients’ guardians. The study was approved by 
the Institutional Review Board of the two participating centers. Cardiac catheterization was 
performed using a biplane Siemens Artis Zee angiographic system (Siemens Healthcare GmbH, 
Erlangen, Germany). General anesthesia was used for all patients. Prior to stenting, a complete 
hemodynamic catheterization was performed, including thermodilution cardiac output (TDCO) 
measurements. Using a 3.5F Millar Mikro-Cath™ Diagnostic Pressure Catheter (Millar Inc., 
Houston, TX) through a guide catheter, pressures were obtained in the left ventricle, ascending 
aorta just above the aortic valve, innominate artery, left carotid artery, left subclavian artery, and 
descending aorta at the level of the diaphragm.  
 
A pre-stent 3DRA was performed with a 6F pigtail catheter in the left ventricle. A contrast 
mixture of 50% contrast (contrast type and dose were institutional standard for 3D) and 50% 
saline was injected over 7 seconds with a 2 second x-ray delay and a 5-second spin. During 
injection, rapid right ventricular pacing at 180-240 paces per minute was performed to decrease 
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the systolic blood pressure by 50%, and a breath hold was performed to minimize motion 
artifact. A low dose spin protocol was used (12 mGy/frame, 1.5 degrees per frame, 30 frames per 
second). The 2D biplane aortic angiogram was used, when available, to determine pulsatility of 
the aorta for elasticity assessment. Aortic coarctation stenting was performed at the operators’ 
discretion. A post-stent 3DRA was performed, using the same protocol as for the pre-stent 
3DRA, and a hemodynamic catheterization was repeated. 
 
CFD Technical Protocol 
The CFD model uses a reduced order formulation of the equations of fluid flow that is designed 
to provide accurate representation of cross-section averaged quantities, such as pressure loss and 
flow in each branch, while sacrificing the ability to capture local flow variations. The model has 
the advantage of being rapid enough to be valuable as a clinical application, taking an average of 
3 minutes of computation time per patient, compared to several hours for typical CFD 
simulators. The model is described in more detail in previous publications (10), where it is 
shown to provide good predictions of catheter-measured PSG based on MR and phase-contrast 
imaging derived flow rates. Specifically, the reduced-order multiscale fluid-structure interaction 
blood flow model is employed to compute pre- and post-stenting hemodynamics. It is based on a 
quasi one-dimensional model for the large arteries and a lumped parameter model (three-element 
Windkessel model), which accounts for the effect of the distal vasculature. To enable accurate 
pressure computation in the coarctation region, a locally defined pressure-drop model is 
embedded into the reduced-order blood flow model (12). Time-varying flow rate profiles are 
used as the inlet boundary condition. A parameter estimation framework is employed for 
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personalizing the hemodynamic computations, comprising two calibration procedures, focusing 
on the cycle-averaged and time-dependent quantities. 
 
In the current work, we extended this model to 3DRA for the anatomic assessment, using 
thermodilution cardiac output to set the inlet boundary condition. Invasively measured pressures 
in the ascending aorta, along with angiographically measured aortic diameters, were used to 
personalize the model parameters, and the PSG across the coarctation was then computed. The 
coarctation geometry was modified to simulate the effect of stenting. The virtual stent location 
was chosen independently from the actual stenting procedure. The stent length and diameter 
were chosen to relieve all stenosis in the descending thoracic aorta, matching the diameter of the 
stent to the aortic diameter on either end of the virtual stent. There were no significant 
differences in the post-stenting actual and predicted anatomical configurations. A post-stent PSG 
was computed, using the same flowrate and personalized model properties as the pre-stent 
computations, in order to simulate real-time work in the CCL (Figure 1). The computational run 
times for the three cases were 147, 190, and 176 seconds (mean time 171 ± 22 seconds). 
 
Case 1 
A 13-year-old 55.5 kg female was referred to the CCL for a severe native coarctation of the aorta 
with an arm-leg cuff PSG of 56 mmHg with upper extremity hypertension (146/52 mmHg). 
Catheterization revealed a discrete, severe coarctation distal to the left subclavian artery. PSG 
was 41 mmHg with a TDCO of 4.7 L/min (Table I), and the CFD processor predicted a PSG of 
40 mmHg. The coarctation was treated with a 36 mm long Cheatham Platinum (CP) stent 
(NuMED, Hopkinton, NY) mounted on a 12 mm Z-Med II-X balloon catheter (NuMED, 
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Hopkinton, NY). The residual PSG across the arch was 14 mmHg, and virtual stenting predicted 
a residual PSG of 10 mmHg (Figure 2 and Table II). 
 
Case 2  
A 16-year-old 69.6 kg male came to the CCL for treatment of a native coarctation of the aorta, 
due to an arm-leg cuff PSG of 50 mmHg with upper extremity hypertension (150/82 mmHg). He 
also had a bicuspid aortic valve, mild aortic regurgitation, and a dilated aortic root. 
Catheterization showed a moderate, discrete coarctation distal to the left subclavian artery with a 
PSG of 29 mmHg and TDCO of 5.7 L/min. CFD predicted a PSG of 29 mmHg. The coarctation 
was treated with a 45 mm long CP stent mounted on a 15 mm Z-Med II-X balloon catheter. The 
residual PSG was 3 mmHg, and, after virtual stenting, the PSG was computed as 2 mmHg 
(Figure 3 and Table II). 
 
Case 3  
A 10-year-old 34.8 kg female underwent catheterization for a native coarctation of the aorta, due 
to an arm-leg cuff PSG of 32 mmHg without upper extremity hypertension. A mild, discrete 
coarctation in the mid-thoracic descending aorta resulted in a PSG of 19 mmHg with a TDCO of 
3.9 L/min. CFD computed a PSG of 18 mmHg. The coarctation was treated with a 39 mm long 
covered CP stent mounted on a 16 mm Balloon in Balloon catheter (NuMED, Hopkinton, NY). 
There was no residual gradient from ascending aorta to descending aorta at catheterization and or 
in the model with virtual stenting (Figure 4 and Table II). 
 
Discussion 
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Since the 1990s, MRI-based CFD advanced from a preclinical modality to clinical application by 
evaluating pathophysiology, surgical and catheter-based treatment planning, and outcome 
prediction. However, clinical data to prove the accuracy of the data obtained from CFD in 
congenital heart disease are still limited. Aside from case reports, two studies have compared 
catheter-based and CFD-based gradients before and after aortic stenting and virtual stenting, 
respectively. First, Goubergrits et al evaluated 13 patients who underwent catheterization and 
preceding MRI, 1 day to 4 weeks apart, for coarctation of the aorta (11). MRI included 3D 
whole-heart and flow-sensitive 4D velocity-encoded sequences (Gyrotools, Zurich, Switzerland). 
CFD assessments were performed using Fluent® 6.3.26 (Ansys, Canonsburg, PA), and the post-
treatment aortic geometry was virtually reconstructed from x-ray images. Pre-stent PSGs 
measured by catheter- and MRI-based CFD correlated significantly with a correlation coefficient 
of 0.97 and an absolute error of -0.5±0.33 mmHg. Post-stent PSGs also correlated significantly 
with a correlation coefficient of 0.87 and absolute error of 3.0±2.91 mmHg (11). 
 
Second, Ralovich et al investigated data sets from 6 coarctation patients who had undergone pre- 
and post-intervention MRI and catheterizations (10). Using MRI-based CFD and virtual stenting, 
there was good agreement between CFD computed PSGs and catheter PSGs with an average 
absolute error of 2.38±0.82 mmHg (pre-stenting), 1.10±0.63 mmHg (post-stenting), and 
4.99±3.00 mmHg (virtual stenting).  
 
To date, 3DRA-based CFD has been used clinically to understand the hemodynamics of brain 
aneurysms and to aid in treatment planning but has not been used in cardiac disease. Because of 
its high spatial resolution, low sensitivity to patient motion, and low visibility of bone, 3DRA has 
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been used as the imaging gold standard when comparing CFD using MRI and CTA (13). Our 
first use of this imaging modality to perform cardiac CFD not only shows feasibility but also 
begins to validate its hemodynamic computations with catheter-based measurements, as all the 
gradients were within 5 mmHg of absolute error. 
 
While CFD predicted the gradients with minimal absolute error, the post-stenting absolute 
pressures were not predicted accurately in all cases. The personalization for both the pre- and 
virtual post-stenting CFD based computations was performed using solely pre-stenting 
hemodynamic measurements, in order to mimic predictive modeling used real-time in the 
catheterization laboratory, during which only pre-stent hemodynamics would be available. For 
example, in Case #1, the patient’s hemodynamics changed quite significantly between the pre- 
and post-stent settings (Table I) with the ascending aortic pressure and TDCO decreasing after 
stent placement. Despite using the pre-stent hemodynamics in the model, a prediction error of 4 
mmHg indicated that the PSG prediction was quite robust and that its accuracy was only 
marginally affected by the change in post-stent hemodynamics. 
 
3DRA-based cardiac CFD is the first step to perform virtual interventions real-time in the CCL 
and to allow CFD to guide management decisions during cardiac catheterization. Previous 
cardiac predictive modeling has used pre-procedural MRI or CTA (14,15). Our novel workflow 
could allow for CFD-guided personalized management decisions even when pre-procedural 
advanced imaging is not performed (14,15). 
 
Limitations 
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The small prediction error (<5 mmHg) is one limitation of CFD, and a detailed uncertainty 
quantification analysis is planned for future studies. Error can come from modeling assumptions, 
anatomical reconstruction errors, inaccurate elastic wall modeling, and inaccuracies in the 
physiological measurements, such as thermodilution cardiac output. The reduced-order 
multiscale model is also limited by its inability to produce 3D streamlines, vortices, and wall 
shear stress. It was chosen for performing the blood flow computations, mainly due to the 
significantly reduced computation time, with an aim of running the calculations real-time, while 
the patient is on the catheterization table.  
 
Conclusion 
The ability to have patient-specific predictive modeling with hemodynamic assessment in the 
CCL will allow clinical decisions regarding stent therapy to be based on robust data, as opposed 
to guessing and assumptions, as it is done now. This may revolutionize the way we make clinical 
decisions and significantly improve care, if this can be done real-time during the catheterization. 
Widespread use of this technology will require large-scale studies to assure reliability and 
validity and to move CFD assessment into the CCL. 
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Figure 1: 3D Rotational Angiography Computational Fluid Dynamics Workflow: (a) 3D 
rotational angiogram (arrow showing discrete coarctation), (b) segmentation, (c) final 3D 
segmented model, (d) boundary conditions added, (e) gradient prediction, (f) virtual stent 
implantation with boundary conditions, and (g) post-stent gradient prediction  
Asc, Ascending; Desc, Descending 
 
Figure 2: Case 1 (a) Dyna CT reconstruction and (b) pressure predictions pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
 
Figure 3: Case 2 (a) Dyna CT reconstruction and (b) pressure predictions pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
 
Figure 4: Case 3 (a) Dyna CT reconstruction and pressure predictions (b) pre-stent and (c) post-
stent 
Asc, Ascending; Desc, Descending; CFD, Computational Fluid Dynamics; Meas, Measured 
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Table I. (A) Pre-stent and (B) post-stent physiologic and anatomical parameters measured at 
catheterization  
A. Pre-stent 














1 104/62 63/53 4.7 101 4.4 16 
2 92/51 63/51 5.7 64 6.8 40 











1 85/52 71/48 3.7 
2 100/54 97/61 6.4 
3 109/71 110/74 5.7 
AAo, Ascending aorta 
DAo, Descending aorta 
BP, Blood pressure 
TDCO, thermodilution cardiac output 
*Pre-stent TDCO was used for post-stent CFD in order to simulate real-time workflow in the 
cardiac catheterization laboratory 
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Table II. Pre-stent and post-stent peak systolic gradients (mmHg) measured by direct 
catheterization pullback (ascending aortic systolic pressure – descending aortic systolic pressure) 
and by Computational Fluid Dynamics  
 Pre-Stent Post-Stent 
Measured CFD* Measured CFD* 
Case 1 41 40 14 10 
Case 2 29 29 3 2 
Case 3 19 18 0 0 
*CFD, Computational Fluid Dynamics 
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